India, May 14 -- The Government of India has issued a release:
In a significant step towards strengthening India's advanced biotechnology and cell therapy ecosystem, the Technology Development Board (TDB), Department of Science & Technology (DST), Government of India, has entered into an agreement with M/s Helix Cell Therapeutics Private Limited, Hyderabad, Telangana for the project titled "Generation of Novel Dual Targeting Chimeric Antigen Receptor T Cells to Treat Multiple Myeloma and Conducting Phase I Clinical Trial." The project is being implemented under the Indo-Singapore collaborative framework in partnership with Biocell Innovations, Singapore.
The project focuses on developing an advanced dual-targeting CAR-T cell therapy for M...